Institute for Evidence-Based Positioning in the Healthcare Sector

Politics, Science and Industry – Working Together for an Efficient Healthcare System

The German healthcare system is undergoing many changes: New regulations, advanced therapies, demographic trends, and rising costs are just a few of them. The offer of innovative treatment options on one side and the principle of contributory stability on the other side pose major challenges for all healthcare stakeholders. The positions and objectives of politics, pharmaceutical industry, payers and associations often seem to be incompatible.

Goals of the institute are an optimal cost-benefit ratio and constructive cooperation of all stakeholders in the healthcare sector. We advise you based on many years of experience – competently and independently.

The rapid evolution of large language models (LLMs) and machine learning (ML) presents both significant opportunities and challenges for market access processes.
In an invited article for the Journal of Medical Economics, I explore the limitations and future potential of AI applications across the individual steps of the Pricing, Reimbursement and Market Access process (PRMA) from a German perspective and in light of the EU HTA Regulation.
Read more: https://www.tandfonline.com/doi/epdf/10.1080/13696998.2025.2488154?needAccess=true

Following a presentation at the World EPA Congress in Amsterdam, an interview with Becaris Publishing, publisher of The Evidence Base, addresses the current role of Real World Evidence (RWE) in Germany, explores the reasons behind the country’s cautious stance, and highlights specific scenarios in which real world data have already been considered — including methodological suggestions from IQWiG: https://becarispublishing.com/digital-content/blog-post/navigating-use-real-world-evidence-drug-assessment-germany-interview-eva-susanne


Vaccinations in focus: new chapter in Springer compendium

Vaccination is a central component of health care – but how are vaccination rates, legislation and economics evolving? In my new chapter ‘Vaccinations’ in the compendium Health Insurance and Care Insurance Management (Springer-Verlag), I examine the role of the STIKO, the legal framework and the challenges for the health care system. I also discuss the growing vaccine market and whether new evaluation methods will be needed to control costs in the future. The full online version can be found here: https://link.springer.com/referenceworkentry/10.1007/978-3-658-31244-2_31-1

What challenges are you facing?

Find me on LinkedIn und XING